Affimed N V Asset Turnover Ratio (AFMD), as of second quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Affimed N v   (NASDAQ: AFMD)
 

Affimed N V Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Affimed N V asset turnover ratio, the ability of Affimed N V 's assets to generate revenue in the second quarter 2024, increased sequentially to 0.11 in the second quarter (Jun 30 2024), yet the ratio remained below the average, as AFMD's position remain challenging.

Within sector 230 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2024 compared to the preceding quarter from 766 to 4216.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AFMD Asset Turnover Ratio (Jun 30 2024)
II. Quarter		 (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Asset Change -47.66 % -49.52 % -57.29 % -51.55 % -57.29 %
Y / Y Revenue Change - -79.99 % - -80.53 % -
Asset Turnover Ratio (TTM) 0.11 0.1 - 0.28 -
AFMD's Total Ranking # 4216 # 766 # 0 # 0 #
Seq. Asset Change -47.66 % 0 % 0 % 0 % -49.52 %
Seq. Revenue Change -98.21 % - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 231
Healthcare Sector # 615
Overall Market # 4216

Asset Turnover Ratio Statistics
High Average Low
0.21 0.17 0.08
(Dec 31 2018)   (Dec 31 2023)




AFMD Company Profile • Back to AFMD Efficiency Comparisons • Compare AFMD Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2024 Assets at quarter ending Jun 30 2024
Fortress Biotech Inc   0.53 $ 82.624  Millions$ 157.101  Millions
Baxter International Inc   0.53 $ 14,861.000  Millions$ 28,258.000  Millions
Ptc Therapeutics inc   0.52 $ 900.454  Millions$ 1,715.392  Millions
Precision Biosciences Inc  0.52 $ 87.640  Millions$ 168.667  Millions
AnTix Holdings, Inc.  0.51 $ 1.825  Millions$ 3.553  Millions
Collegium Pharmaceutical Inc   0.51 $ 575.318  Millions$ 1,122.131  Millions
Lifecore Biomedical Inc   0.51 $ 127.850  Millions$ 249.842  Millions
Charles River Laboratories International inc   0.51 $ 4,077.776  Millions$ 7,975.769  Millions
G1 Therapeutics Inc   0.51 $ 58.195  Millions$ 113.838  Millions
Axsome Therapeutics Inc   0.51 $ 291.489  Millions$ 570.762  Millions
Harrow Inc   0.51 $ 152.987  Millions$ 300.099  Millions
Pacific Health Care Organization Inc  0.51 $ 5.986  Millions$ 11.762  Millions
Ge Healthcare Technologies Inc   0.51 $ 16,351.000  Millions$ 32,224.000  Millions
Immucell Corporation  0.51 $ 21.889  Millions$ 43.315  Millions
Johnson and Johnson  0.50 $ 86,576.000  Millions$ 171,668.250  Millions
Cutera Inc   0.50 $ 168.842  Millions$ 335.303  Millions
Livanova Plc  0.50 $ 1,208.205  Millions$ 2,417.943  Millions
Transmedics Group Inc   0.50 $ 358.759  Millions$ 719.421  Millions
Fonar Corporation  0.50 $ 102.884  Millions$ 206.924  Millions
Nexgel Inc   0.50 $ 4.979  Millions$ 10.016  Millions
Cryo cell International Inc   0.50 $ 31.642  Millions$ 63.824  Millions
Ontrak Inc   0.49 $ 11.442  Millions$ 23.153  Millions
3m Company  0.49 $ 24,543.000  Millions$ 49,705.250  Millions
Bristol myers Squibb Company  0.49 $ 46,509.000  Millions$ 95,024.750  Millions
Adaptimmune Therapeutics Plc  0.49 $ 141.459  Millions$ 289.742  Millions
Illumina Inc   0.49 $ 4,429.000  Millions$ 9,088.500  Millions
Tenon Medical Inc   0.49 $ 3.372  Millions$ 6.922  Millions
Supernus Pharmaceuticals inc   0.49 $ 630.163  Millions$ 1,295.688  Millions
Revance Therapeutics Inc   0.48 $ 243.900  Millions$ 503.465  Millions
Steris Plc  0.48 $ 5,234.817  Millions$ 10,818.694  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.